Key Takeaways:

• Launched in November 2024 and already posting $108 million ARR, IM8 is tracking as the fastest-growing brand in the $400B+ global supplement industry.
• Soccer supernova David Beckham, co-founder and equity stakeholder, has been involved from inception.
• Blending 90+ ingredients into its star Daily Ultimate Essentials formula, IM8 seeks to streamline supplement intake and save health enthusiasts serious cash.

In an era when health-focused consumers can fuel up on comically large regimens of pills, powders, and potions, it’s hardly a shocker that the “one and done” ethos behind IM8, which weaves 92 ingredients into its signature formula, has taken off like a rocket. Of course, the fact that the year-old, Hong Kong–based supplements brand is backed in part by beloved soccer icon David Beckham certainly hasn’t hurt on the instant-credibility front. Not to mention Aryna Sabalenka, the reigning world No. 1 women’s tennis champ, who also has a stake in the brand.

According to co-founder and CEO Danny Yeung, who holds equivalent titles at IM8’s parent, Hong Kong–based biotech company Prenetics, the brand’s intriguing moniker is a declaration of self-empowerment and identity.

“The number 8 symbolizes balance, infinity, and continuous improvement, reflecting our commitment to ongoing personal development and well-being,” Yeung said to BeautyMatter. “Our mission is to support individuals in achieving and maintaining optimal well-being by providing the nutritional support to boldly declare, ‘I am strong, I am healthy, I am capable,’ and live out that affirmation every day.”

And at least from a business standpoint, “I am extraordinarily fast to market and fully industry-disruptive”could also be pillars of the IM8 origin story.

Connected through a mutual friend, Yeung and Beckham had dinner in Hong Kong at the tail end of 2023, and over breaking bread, IM8 was born. “There was no agenda, no pitch,” Yeung recalled. “The idea of building a supplement brand came out of a natural conversation about health, performance, and what we both felt was missing.”

In a first for Beckham, he opted to come in on the ground floor as a co-founder. “It was the first time in his career he had taken an ownership stake in a health supplements company, after turning down approaches from major corporations and startups,” Yeung shared. “He said yes because the entire premise was uncompromising science, quality, and taste.”

After that one meal, the pair set to work at a rapid clip, launching in November 2024 with two formulas: Daily Ultimate Essentials and Daily Ultimate Longevity. Both feature staggering amounts of ingredients across the categories of multivitamins, minerals, antioxidants, superfoods, greens, fruits, electrolytes, adaptogens, probiotics, and more.

“We moved quickly by running formulation, brand, regulatory, and supply chain in parallel, anchored by Prenetics’ infrastructure and our scientific advisory board,” said Yeung. Despite the accelerated timeline, “Speed never came at the expense of evidence.”

Understandably, operations proved to be the trickiest piece of the puzzle. “We launched in more than 30 countries on Day One, which meant navigating regulations, logistics, and customer service in multiple markets simultaneously,” said Yeung. “Building that global backbone in under a year was the real warp-speed challenge, and it’s what gave us the foundation to scale.”

But without a true point of difference, IM8 surely wouldn’t have been able to make a dent in the global supplements market, which Grandview Research estimated at $193 billion in 2024. And yet it has, delivering 13 million servings to 420K customers across 34 countries, yielding $108 million in first-year ARR (Annualized Recurring Revenue). 

To lay a firm, research-backed foundation, IM8 deployed an 11-member Scientific Advisory Board to develop its formulas, populated with experts from Mayo Clinic, Yale-Griffin, and NASA.

To secure a next-level degree of efficacy and potency, Yeung and Beckham also tasked the San Francisco Research Institute with conducting a 12-week randomized, controlled clinical trial on the brand’s flagship product, Daily Ultimate Essentials.

“This wasn’t just ingredient testing,” said Yeung. “It measured how well our complete formula actually works in real people, examining both self-reported outcomes and objective biological markers.”

In addition to its own biomarker analysis, the team solicited participant feedback. Within 30 days of testing, they were reporting a noticeable boost in daily energy (95%); less bloating and improved digestion (85%); better sleep (80%), and improved focus and mental clarity (75%).

“We chose independent third-party validation because it’s the gold standard for credibility,” said Yeung. “External research institutes and certification bodies confirm our claims are backed by unbiased science, rather than just internal testing.”

So how much does all this powdered performance-enhancing cost the consumer? A 30-day supply of Daily Ultimate Essentials is available for a $112 one-time purchase or $89 per month via a monthly subscription. Daily Ultimate Longevity is slightly pricier, clocking in at $149 for a one-time purchase and $119 for a monthly subscription. For both products, 90-day purchases substantially lower the daily price of consumption.

Although the IM8 website is sprinkled liberally with cost-saving shout-outs (“Incredible Value: Save 53% Vs Individual Supplements”) and even estimates of the precise amount one would spend on specific ingredients should they go the one-by-one route, evidently the bigger draw for IM8 enthusiasts is convenience.

“IM8’s core USP is simplifying daily nutrition without compromising efficacy,” said Yeung. “Rather than juggling multiple single-benefit supplements, our formula contains 92 clinically validated ingredients, including vitamins, minerals, probiotics, adaptogens, and nootropics, into a single scoop that supports energy, immunity, digestion, and cognitive function.”

Yeung is also quick to point out that not only is every ingredient in Daily Ultimate Essentials third-party tested, it’s also NSF Certified for Sport, meaning that it’s free from more than 280 banned substances, heavy metals, and contaminants. Undoubtedly this is a key reason why mega-athletes like Sabalenka, who are drug-tested on a regular basis for banned ingredients, feel confident using it.

In a product sector heavily weighted toward retail—Yeung’s research shows that 71% of the supplement industry relies on brick and mortar—IM8 is content, for the moment, with DTC.

“We’re currently laser-focused on our direct-to-consumer model, and it’s working exceptionally well,” said Yeung. “IM8 is scaling faster than legacy players through subscription retention in a category typically dominated by one-off purchases. We’ve achieved an 80% subscription rate.”

Which isn’t to say Yeung has zero physical-store aspirations. “Retail is part of our long-term vision,” he allowed. “We want to meet our customers where they are, whether that’s Erewhon, Whole Foods, Target, or other elevated retail environments known for premium, curated products.”

For the moment, however, goals include perfecting the product and user experience. “When we do enter retail, it will be strategic, selective, and aligned with our brand standards,” said Yeung. “We’d rather be in the right places than everywhere.”

Having recently expanded into Eastern Europe, IM8 is now available in 45 countries and is busily overhauling US logistics to enable two-day national shipping. In Q1 2026, Yeung expects to launch warehouse hubs in the UK and EU.

“We’re scaling our infrastructure as aggressively as our revenue to ensure speed never comes at the expense of quality,” said Yeung. “With this global momentum, we’re excited to introduce several new product lines to our community next year.”

Within the next five years, Yeung wants nothing less for IM8 than to serve as the global standard for daily health and performance and to be recognized as the industry go-to for obliterating the complexity of modern supplementation.

“The ambition is bigger than a single product,” said Yeung. “IM8 is the front door to a next-generation personalized health platform, moving beyond one-size-fits-all supplements toward an integrated ecosystem that combines science-backed nutrition, diagnostics, and data to deliver interventions tailored to each person’s biology and lifestyle.”

This “ecosystem,” as Yeung deemed it, will drive future brand growth. “As it scales, every interaction feeds a learning loop that sharpens personalization, builds defensible IP, and deepens our understanding of how behavior and biology drive performance and long-term health.”